Detalles de la búsqueda
1.
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases.
Br J Cancer
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745088
2.
Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.
Br J Cancer
; 130(3): 442-449, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102227
3.
Infliximab desensitization in patients with inflammatory bowel diseases: a safe therapeutic alternative.
Scand J Gastroenterol
; 59(5): 553-560, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353236
4.
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
Gut
; 72(4): 699-709, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35803702
5.
Complete pathological response after chemotherapy or immune checkpoint inhibitors in deficient MMR metastatic colorectal cancer: Results of a retrospective multicenter study.
Int J Cancer
; 153(7): 1376-1385, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37403609
6.
Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD).
BMC Cancer
; 23(1): 17, 2023 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604640
7.
Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis.
Lancet Oncol
; 23(10): 1332-1342, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36058227
8.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer
; 126(9): 1264-1270, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992255
9.
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Int J Mol Sci
; 23(8)2022 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35457245
10.
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
Int J Cancer
; 148(7): 1731-1742, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186471
11.
Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer.
BMC Med Res Methodol
; 21(1): 14, 2021 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33422006
12.
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
Gut
; 69(3): 531-539, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31101691
13.
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients.
Int J Cancer
; 147(4): 967-977, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31912484
14.
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study.
Int J Cancer
; 147(1): 285-296, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31970760
15.
Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial.
Br J Cancer
; 122(7): 957-962, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32015513
16.
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey.
Oncologist
; 24(12): e1351-e1359, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31324663
17.
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study.
Br J Cancer
; 119(4): 424-428, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29872148
18.
Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.
Int J Colorectal Dis
; 33(8): 1125-1130, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29680896
19.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
20.
Preferences about information and decision-making among older patients with and without cancer.
Age Ageing
; 46(4): 665-671, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28104597